agilon health (NYSE:AGL – Get Rating) had its target price upped by Deutsche Bank Aktiengesellschaft from $26.00 to $28.00 in a research note issued to investors on Friday morning, The Fly reports.
A number of other analysts have also recently issued reports on the stock. SVB Leerink reduced their target price on shares of agilon health from $33.00 to $30.00 and set an outperform rating for the company in a research note on Friday, November 4th. Wells Fargo & Company reduced their price objective on shares of agilon health from $28.00 to $22.00 and set an overweight rating for the company in a research note on Tuesday, November 15th. Stifel Nicolaus began coverage on shares of agilon health in a research note on Thursday, December 8th. They issued a buy rating and a $23.00 price objective for the company. Finally, The Goldman Sachs Group reduced their price objective on shares of agilon health from $38.00 to $34.00 and set a buy rating for the company in a research note on Tuesday, November 15th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average price target of $28.63.
agilon health Price Performance
NYSE AGL opened at $25.22 on Friday. The company has a quick ratio of 2.48, a current ratio of 2.71 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $10.42 billion, a PE ratio of -97.00 and a beta of 1.09. The company has a 50 day moving average price of $20.31 and a two-hundred day moving average price of $20.19. agilon health has a 12-month low of $14.82 and a 12-month high of $28.36.
Insider Buying and Selling
Institutional Investors Weigh In On agilon health
Several institutional investors and hedge funds have recently bought and sold shares of AGL. FMR LLC increased its holdings in agilon health by 14.9% in the 2nd quarter. FMR LLC now owns 34,862,287 shares of the company’s stock valued at $761,043,000 after buying an additional 4,512,008 shares during the period. Vanguard Group Inc. increased its holdings in agilon health by 14.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,770,560 shares of the company’s stock valued at $439,605,000 after buying an additional 2,407,116 shares during the period. Durable Capital Partners LP increased its holdings in agilon health by 34.0% in the 3rd quarter. Durable Capital Partners LP now owns 9,429,055 shares of the company’s stock valued at $220,828,000 after buying an additional 2,392,134 shares during the period. Wellington Management Group LLP grew its holdings in shares of agilon health by 11.0% in the 1st quarter. Wellington Management Group LLP now owns 18,578,035 shares of the company’s stock worth $470,953,000 after purchasing an additional 1,834,890 shares during the last quarter. Finally, Capital Research Global Investors grew its holdings in shares of agilon health by 18.4% in the 1st quarter. Capital Research Global Investors now owns 9,867,875 shares of the company’s stock worth $250,151,000 after purchasing an additional 1,536,506 shares during the last quarter.
About agilon health
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.